Filing Details
- Accession Number:
- 0001179110-12-003877
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-01 16:32:47
- Reporting Period:
- 2012-02-29
- Filing Date:
- 2012-03-01
- Accepted Time:
- 2012-03-01 16:32:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884629 | Watson Pharmaceuticals Inc | WPI | Pharmaceutical Preparations (2834) | 953872914 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1241752 | D Charles Ebert | Morris Corporate Center Iii 400 Interpace Parkway Parsippany NJ 07054 | Sr. Vp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0033 | Acquisiton | 2012-02-29 | 1,000 | $25.64 | 27,264 | No | 4 | M | Direct | |
Common Stock, Par Value $0.0033 | Disposition | 2012-02-29 | 1,000 | $58.77 | 26,264 | No | 4 | S | Direct | |
Common Stock, Par Value $0.0033 | Disposition | 2012-02-29 | 3,981 | $58.81 | 22,283 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0033 | Incentive Stock Options to Purchase Common Stock | Disposition | 2012-02-29 | 1,000 | $0.00 | 1,000 | $25.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-09-01 | 2016-09-01 | No | 4 | M | Direct |
Footnotes
- Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.